Point72 Asset Management
AMED

Point72 Asset Management’s Amedisys AMED Stock Holding History

Point72 Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200,000
Closed -$12.6M – 861
2017
Q2 		$12.6M Buy
+200,000
New +$11.6M 0.07% 344

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Point72 Asset Management's AMED Position: Q1 2023 in Review

Point72 Asset Management sold out of Amedisys (AMED) in Q1 2023, closing a stake of 551,468 shares — an estimated $46.1M sold.

Point72 Asset Management first reported a position in AMED in Q3 2014 and held it in 16 quarters. The position peaked at $104M in Q3 2022. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

  • Point72 Asset Management reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
  • Point72 Asset Management sold 551,468 Amedisys shares in Q1 2023, an estimated $46.1M.
  • Point72 Asset Management first reported a position in Amedisys in Q3 2014 and held it in 16 quarters.
  • Point72 Asset Management's Amedisys position peaked at $104M in Q3 2022.
  • 281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Point72 Asset Management's 13F filing for Q1 2023, filed 15 May 2023.